NCT01450774View on ClinicalTrials.gov

Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

February 28, 2014

Conditions
Childhood Asthma
Interventions
DRUG

CHF 1535 50/6µg

fixed combination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg

DRUG

beclomethasone dipropionate 50µg + formoterol fumarate 6µg

free combination of beclomethasone dipropionate 50µg + formoterol fumarate 6µg

Trial Locations (1)

2100

BørneAstmaKlinikken, Copenhagen

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01450774 - Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children | Biotech Hunter | Biotech Hunter